Summary: CoreWeave, Inc. (CRWV) reported a scheduled insider sale by its general counsel and presented quarterly results that combined dramatic revenue gains with narrower-than-expected margins. The transaction followed a trading plan established in May 2025, and the company continues to draw varied responses from sell-side analysts after releasing its fourth-quarter 2025 financials.
According to a Form 4 filed with the Securities and Exchange Commission, Kristen J. McVeety, CoreWeaves General Counsel and Secretary, sold 2,601 shares of Class A common stock on February 26, 2026. The shares were disposed of at prices between $95.769 and $100.3986, producing total proceeds of $261,554. The filing indicates the trades were made pursuant to a pre-arranged trading plan that was adopted on May 28, 2025. After the transactions, McVeety directly holds 120,079 shares of CoreWeave Class A common stock.
The company's share price has since moved lower to $79.53. An InvestingPro analysis referenced in company materials suggests CoreWeave appears undervalued at current levels.
Quarterly results and backlog: CoreWeave reported fourth-quarter revenue of $1.6 billion for 2025, representing a 110% year-over-year increase. The firms revenue backlog expanded from $55.6 billion to $66.8 billion, a rise the company attributes in part to a new agreement with Meta valued at approximately $5 billion.
Despite the rapid top-line expansion, CoreWeaves adjusted operating margin for the period came in at 5.6%, short of the 8.6% consensus among analysts. The company remains unprofitable on a net basis and has a market capitalization of $50.9 billion. Over the past year the stock has returned 99%.
Analyst reactions: Brokerages have responded with varying updates to their price targets and ratings following the results. DA Davidson increased its price target to $125 and maintained a Buy rating. Cantor Fitzgerald reiterated an Overweight rating with a $131 target. Stifel cut its price target to $110 but kept a Hold rating, citing margin performance and increased capital expenditures as drivers of caution. Goldman Sachs held a Neutral rating, pointing to margin pressures and higher-than-expected capital spending. JPMorgan lowered its price target to $90 from $110, expressing valuation concerns while retaining a Neutral stance.
Investor resources: For investors seeking additional analysis, a comprehensive Pro Research Report on CoreWeave is available, covering this company among more than 1,400 U.S. equities.